Christos Kosmas
Christos Kosmas
Consultant Medical Oncologist, "Metaxa" Cancer Hospital, 18537 Piraeus, Greece
Verified email at
Cited by
Cited by
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with …
J Tabernero, T Yoshino, AL Cohn, R Obermannova, G Bodoky, ...
Lancet Oncol 16 (5), 499-508, 2015
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
N Tsavaris, C Kosmas, M Vadiaka, P Kanelopoulos, D Boulamatsis
British journal of cancer 87 (1), 21-27, 2002
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
C Kosmas, MS Kallistratos, P Kopterides, J Syrios, H Skopelitis, ...
Journal of cancer research and clinical oncology 134 (1), 75-82, 2008
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience
A Polyzos, N Tsavaris, C Kosmas, T Arnaouti, N Kalahanis, C Tsigris, ...
Oncology 61 (2), 129-133, 2001
A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian …
A Polyzos, N Tsavaris, C Kosmas, L Giannikos, M Katsikas, N Kalahanis, ...
Oncology 56 (4), 291-296, 1999
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy
C Kosmas, D Snook, CS Gooden, NS Courtenay-Luck, MJ McCall, ...
Cancer Research 52 (4), 904-911, 1992
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study
N Tsavaris, C Kosmas, H Skopelitis, P Gouveris, P Kopteridis, D Loukeris, ...
Investigational new drugs 23 (4), 369-375, 2005
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial
D Mavroudis, N Malamos, A Alexopoulos, C Kourousis, S Agelaki, E Sarra, ...
Annals of oncology 10 (2), 211-216, 1999
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer
N Tsavaris, C Kosmas, P Gouveris, K Gennatas, A Polyzos, D Mouratidou, ...
Investigational new drugs 22 (2), 193-198, 2004
Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell …
N Mylonakis, A Athanasiou, N Ziras, J Angel, A Rapti, S Lampaki, N Politis, ...
Lung cancer 68 (2), 240-247, 2010
Molecular insights into the immunopathogenesis of follicular lymphoma
K Stamatopoulos, C Kosmas, C Belessi, N Stavroyianni, P Kyriazopoulos, ...
Immunology today 21 (6), 298-305, 2000
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy–a survey of 427 patients
N Tsavarisabcdef, C Kosmasabcdef, M Vadiakabcdf, M Efremidisbcdf, ...
Signature 8 (6), 57, 2002
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer
C Kosmas, NB Tsavaris, NA Malamos, M Vadiaka, C Koufos
Journal of clinical oncology 19 (1), 119-126, 2001
Anti-CD20-based therapy of B cell lymphoma: state of the art
C Kosmas, K Stamatopoulos, N Stavroyianni, N Tsavaris, T Papadaki
Leukemia 16 (10), 2004-2015, 2002
Predictors of survival in stage IV metastatic colorectal cancer
M Zacharakis, ID Xynos, A Lazaris, T Smaro, C Kosmas, A Dokou, ...
Anticancer research 30 (2), 653-660, 2010
Follicular lymphoma immunoglobulin κ light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains
K Stamatopoulos, C Kosmas, T Papadaki, E Pouliou, C Belessi, ...
British journal of haematology 96 (1), 132-146, 1997
Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study
N Tsavaris, P Kopterides, C Kosmas, A Efthymiou, H Skopelitis, ...
Pain Medicine 9 (8), 1209-1216, 2008
Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer
A Maraveyas, D Snook, V Hird, C Kosmas, CF Meares, HE Lambert, ...
Cancer 73 (S3), 1067-1075, 1994
Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis
S Sougioultzis, J Syrios, ID Xynos, N Bovaretos, C Kosmas, J Sarantonis, ...
European Journal of Surgical Oncology (EJSO) 37 (4), 312-318, 2011
Tumour localisation with a radioactively labelled reshaped human monoclonal antibody
V Hird, M Verhoeyen, RA Badley, D Price, D Snook, C Kosmas, C Gooden, ...
British journal of cancer 64 (5), 911-914, 1991
The system can't perform the operation now. Try again later.
Articles 1–20